Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Pharma
Weight loss drugs from Lilly, Novo may cut risk of Alzheimer's
A study indicates that new weight loss drugs may reduce the risk of Alzheimer’s disease while increasing the risk of other disorders.
Kevin Dunleavy
Jan 21, 2025 2:45pm
Roche projected to claim pharma's 2025 sales crown: Evaluate
Jan 3, 2025 1:07pm
Lilly seeks to intervene in compounded tirzepatide lawsuit
Jan 2, 2025 4:16pm
Lilly's Zepbound scores 2nd FDA nod, this time in sleep apnea
Dec 20, 2024 4:50pm
Compounders protest as FDA removes tirzepatide from shortage list
Dec 19, 2024 3:22pm
High-flying Eli Lilly plots $15B share buyback campaign
Dec 10, 2024 11:31am
